Abstract

Objective: Complete resection of disease is the most important prognostic factor for patients with low-grade serous ovarian carcinoma (LGSOC). However, the implication of carcinomatosis distribution and implant size according to their location is poorly investigated. Our objective was to assess the impact of peritoneal carcinomatosis quantitative and qualitative localizations on progression-free survival (PFS) and overall survival (OS) in patients with LGSOC after complete cytoreductive surgery.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call